Hospital General de Niños Pedro de Elizalde
16
0
1
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 55/100
25.0%
4 terminated/withdrawn out of 16 trials
73.3%
-13.2% vs industry average
25%
4 trials in Phase 3/4
55%
6 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
Analysis of Variability in the Management of Respiratory Infections in Hospitalized Patients Under 2 Years of Age
Role: lead
Losartan and Uric Acid Metabolism in Children With Proteinuric Nephropathies
Role: lead
Validation of a Questionnaire for Quality of Life Assessment in Patients With Transthyretin Amyloidosis.
Role: lead
Non-attendance Prediction Models to Pediatric Outpatient Appointments
Role: lead
Pediatric Virtual Visits as a Strategy for Access to Care During the COVID-19 Pandemic in a Pediatric Hospital
Role: lead
Erythropoietin in Hemolytic Uremic Syndrome
Role: lead
Randomized, Double-blind, Placebo, Controlled Cross Over Design Topical Morphine for Analgesia in Pediatric Procedures
Role: lead
Flexible Catheter for Insulin in Diabetes
Role: lead
Use of Corticosteroids in Children With Cellulitis
Role: lead
Bacterial Pneumonia Score (BPS) Guided Antibiotic Use in Children With Pneumonia and Pneumococcal Vaccine
Role: lead
Variation in Natremia Using Two Different Maintenance Intravenous Fluids in Postsurgical Hospitalized Children
Role: lead
Efficacy of Nebulized Hypertonic Saline in the Treatment of Acute Bronchiolitis
Role: lead
Two Bag System for Hydration in Diabetes
Role: lead
Bacterial Pneumonia Score (BPS) Guided Antibiotic Use in Children With Community Acquired Pneumonia
Role: lead
Corticosteroids in Community-acquired Pneumonia
Role: lead
0.9% NaCl/Dextrose 5% vs 0.45% NaCl/Dextrose 5% as Maintenance Intravenous Fluids in Critically Ill Children
Role: lead
All 16 trials loaded